Federal Register Notice: FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will meet 10/21, from 8 a.m. to 5 p.m. at the Crowne Plaza Hotel/Washington DC-Silver Spring, The Ballrooms, 8777 Georgia Ave., Silver Spring, MD. On 10/21 the committee session will be closed from 8 a.m. to 11 a.m. The meeting will be open to the public from 11 a.m. to 5 p.m. during which the committee will discuss the safety and efficacy of Genzyme Corp.’s BLA for Myozyme (alglucosidase alfa) for treating late onset Pompe disease. Contact Paul Tran, (301) 827-7001. To view this notice, click here.